Atopic Dermatitis Primer for AAD 2025: Dermatologist Mona Shahriari, MD, Explains the Rise in Prevalence
Shahriari, assistant clinical professor of dermatology at Yale University School of Medicine, says greater understanding of the condition has expanded the population for the diagnosis.
Atopic dermatitis appears to be more common now than it was 10 or 15 years ago, according to Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University School of Medicine in New Haven, CT. One of the primary reasons, she explained in a recent interview with Patient Care,® is that "how we define [the condition] is starting to shift. We are starting to recognize it as a spectrum that is much more complex than we once thought." In this short video, Shahriari elaborated on how broader and deeper understanding of the pathophysiology of eczema, of its heterogeneity, and of at-risk populations is expanding the population for an accurate diagnosis.
Mona Shahriari, MD, is assistant clinical professor of dermatology at Yale University School of Medicine in New Haven, Connecticut and co-founder of Central Connecticut Dermatology in Cromwell, Connecticut.
Ruxolitinib Cream 1.5% Demonstrates Efficacy in Prurigo Nodularis: Phase 3 Findings
March 8th 2025Data from the TRuE-PN trial program were presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, offering important insights into potential new therapeutic options for this debilitating condition.
